Valion Bio (VBIO) Financial Statements

167 Followers

Valion Bio Financial Overview

Valion Bio's market cap is currently $3.01M. The company's EPS TTM is $-0.01; its P/E ratio is -0.05; Valion Bio is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 22	Mar 20	Mar 19	Mar 18	Mar 17
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 102.42K	$ 163.36K
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 24.48K	$ 55.10K
Operating Income	$ -2.34M	$ -3.69M	$ -4.57M	$ -4.40M	$ -3.47M
EBITDA	$ -880.85K	$ -4.37M	$ -4.43M	$ -4.31M	$ -5.22M
Net Income	$ -880.85K	$ -4.37M	$ -20.14M	$ -4.31M	$ -5.22M
Balance Sheet
Cash & Short-Term Investments	$ 884.14K	$ 2.39M	$ 5.98M	$ 656.29K	$ 1.15M
Total Assets	$ 896.83K	$ 2.57M	$ 6.08M	$ 675.79K	$ 1.18M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -884.14K	$ -2.39M	$ -5.98M	$ -656.29K	$ -1.15M
Total Liabilities	$ 33.44K	$ 1.28M	$ 1.05M	$ 353.52K	$ 800.65K
Stockholders' Equity	$ 863.39K	$ 1.28M	$ 5.02M	$ 322.27K	$ 374.37K
Cash Flow
Free Cash Flow	$ -1.61M	$ -3.59M	$ -3.67M	$ -2.89M	$ -1.38M
Operating Cash Flow	$ -1.61M	$ -3.59M	$ -3.67M	$ -2.89M	$ -1.38M
Investing Cash Flow	$ 0.00	$ 0.00	$ 141.54K	$ 0.00	$ 0.00
Financing Cash Flow	$ 96.99K	$ 0.00	$ 8.85M	$ 2.39M	$ 2.44M

Currency in USD

Valion Bio Earnings and Revenue History

Income Statement >

Valion Bio Debt to Assets

Balance Sheet >

Valion Bio Cash Flow

Cash Flow >

Valion Bio Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >